The Organ Preservation Market Revenue is expected to grow US$ 455 Million by 2032, up from 230 million in 2021, at a 6.4% CAGR during the forecast period.

Organ Preservation Market Overview:

Organ preservation is the practise of preserving healthy organs removed from donors’ bodies. Organs are extracted from the donor’s body, transported, and then transplanted into the recipient’s body without causing significant damage. According to the findings of this study, the rising prevalence of chronic illnesses has a direct impact on the adoption of organ preservation.

Organ preservation for transplantation has a strong influence on donor organ quality, which has a direct impact on a patient’s morbidity and survival rates following transplantation. One of the major factors driving the growth of the organ preservation solutions market is the increasing prevalence of chronic illnesses, as well as the world’s growing elderly population.

Because of the increasing number of organ failures caused by diabetes, cardiovascular diseases (CVDs), obesity, and other serious medical problems, static cold storage organ preservation treatments are becoming more common. Innovative and sophisticated organ preservation strategies, such as NMP, act as a growth-inducing agent.

Key Takeaways:

• A preservation injury occurs when the liver no longer functions. A liver transplant, also known as a hepatic transplant, has the potential to save someone’s life. A liver transplant may also be recommended by a doctor to a patient who has reached the end stage of liver disease.
• Individuals who received a liver transplant had an 89% chance of survival after one year, according to an article published in the American Journal of Transplantation. The growing need for organ transplantation is propelling the global organ preservation market across the board.
• According to the American Transplant Foundation, approximately 114,000 people in the United States are currently on the waiting list for a life-saving organ transplant. Every day, on average, 20 people die due to a lack of available organs for transplantation.

Competition Analysis:

The global organ preservation market is dominated by companies such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut (Netherlands).

To learn more about this report @ https://www.futuremarketinsights.com/reports/organ-preservation-market